Sustained aryl hydrocarbon receptor activity attenuates liver regeneration

Molecular Pharmacology
Kristen A MitchellCornelis J Elferink

Abstract

In hepatocyte-derived cell lines, either loss of aryl hydrocarbon receptor (AhR) function or treatment with a persistent AhR agonist such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) can disrupt G1 phase cell cycle progression. The present study used liver regeneration to explore mechanistically how AhR activity modulates hepatocyte proliferation in vivo. Treatment of mice with 20 mug/kg TCDD 1 day before 70% partial hepatectomy (PH) resulted in a 50 to 75% suppression in liver regeneration. Impaired proliferation was not associated with changes in levels of interleukin-6 or tumor necrosis factor-alpha, which prime quiescent hepatocytes to enter G1 phase. In fact, administration of TCDD 12 h after PH, a period well beyond the priming phase, still induced the G1 arrest. Decreased proliferation in TCDD-treated mice correlated with reduced cyclin-dependent kinase-2 (CDK2) activity, a pivotal regulator of G1/S phase transition. In contrast to observations made in cell culture, suppressed CDK2 activity was not strictly associated with increased binding of the CDK2 inhibitors p21Cip1 or p27Kip1. However, TCDD decreased levels of cyclin E binding to CDK2, despite normal cyclin E expression. The evidence also suggests that TCDD-induce...Continue Reading

References

Dec 1, 1991·Toxicology and Applied Pharmacology·M Göttlicher, F J Wiebel
Feb 1, 1989·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·J B SilkworthG Sack
May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Nov 1, 1995·International Journal of Immunopharmacology·R A PrellN I Kerkvliet
Mar 1, 1997·Critical Reviews in Toxicology·J C Rowlands, J A Gustafsson
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·T C Weglarz, E P Sandgren
Oct 22, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Tomohiro ItoKeiko Nohara
Mar 26, 2003·Liver International : Official Journal of the International Association for the Study of the Liver·David MangnallAli W Majeed
Oct 11, 2003·Molecular Cell·Markus WelckerJames M Roberts
Dec 18, 2003·Environmental Health : a Global Access Science Source·Brenda A JensenDavid H Sherr
Jan 27, 2004·Molecular Pharmacology·Aviva Levine-FridmanCornelis J Elferink
Oct 20, 2004·Molecular Pharmacology·Gengming Huang, Cornelis J Elferink
May 19, 2005·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Prabir K Mandal
Nov 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jacqueline A WalisserChristopher A Bradfield

❮ Previous
Next ❯

Citations

Sep 25, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ted SimonRobert A Budinsky
Feb 3, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Michael B BlackJ Craig Rowlands
Dec 4, 2012·Toxicological Sciences : an Official Journal of the Society of Toxicology·Peter HofsteenWarren Heideman
May 23, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lijoy K MathewRobert L Tanguay
Dec 28, 2012·The Journal of Pharmacology and Experimental Therapeutics·Tod A HarperCornelis J Elferink
Apr 5, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Lindsey N JacksonB Mark Evers
Jun 9, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Betina J LewB Paige Lawrence
Feb 7, 2015·Pharmacological Reviews·Charlotte Esser, Agneta Rannug
Feb 13, 2015·The Journal of Pharmacology and Experimental Therapeutics·Aditya D JoshiCornelis J Elferink
Mar 21, 2013·The Journal of Pharmacology and Experimental Therapeutics·Shelly R WilsonCornelis J Elferink
Jan 17, 2014·Molecular Pharmacology·Daniel P JacksonCornelis J Elferink
Jul 8, 2015·Journal of Cheminformatics·Sunghwan KimStephen H Bryant
Apr 7, 2007·FEBS Letters·Robert BaroukiPedro M Fernandez-Salguero
Jul 3, 2007·Viral Immunology·B Paige Lawrence
Jun 29, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rushang D PatelGary H Perdew
Aug 25, 2016·Journal of Inflammation·Stephanie L WylerKristen A Mitchell
Jun 4, 2010·International Journal of Cancer. Journal International Du Cancer·Tao WangBeth A Vorderstrasse
Aug 27, 2010·Journal of Experimental Neuroscience·Amy T McCurley, Gloria V Callard
Jul 24, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Qinggong YuanAmar Deep Sharma
Apr 26, 2012·Journal of Immunotoxicology·Christopher J HorrasKristen A Mitchell
Sep 7, 2017·Scientific Reports·Nuria Moreno-MarínPedro M Fernández-Salguero
Oct 14, 2017·Toxicological Sciences : an Official Journal of the Society of Toxicology·Martin R BrownMark J Graham
Nov 5, 2019·Frontiers in Microbiology·Francisco Arenas-HuerteroRafael Valencia-Quintana
May 20, 2021·Toxicological Sciences : an Official Journal of the Society of Toxicology·Hesbon A ZablonAlvaro Puga
May 23, 2021·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Lenny KameliaPeter J Boogaard
Oct 22, 2008·Biochemical Pharmacology·Lijoy K MathewRobert L Tanguay
Nov 26, 2008·Biochemical Pharmacology·Kristen A Mitchell, Cornelis J Elferink
Jun 21, 2011·Differentiation; Research in Biological Diversity·Vatsal Mehta, Chad M Vezina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.